0001683553-25-000003.txt : 20251017 0001683553-25-000003.hdr.sgml : 20251017 20251016183431 ACCESSION NUMBER: 0001683553-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251017 DATE AS OF CHANGE: 20251016 EFFECTIVENESS DATE: 20251017 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001683553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 812154263 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-561207 FILM NUMBER: 251398636 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BOULEVARD, SUITE 740 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (415) 655-4168 MAIL ADDRESS: STREET 1: 611 GATEWAY BOULEVARD, SUITE 740 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001683553 SPRUCE BIOSCIENCES, INC. 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 (415) 655-4168 DELAWARE None None Corporation true Javier Szwarcberg c/o Spruce Biosciences, Inc. 611 Gateway Boulevard, Suite 740 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Bali Muralidhar c/o Spruce Biosciences, Inc. 611 Gateway Boulevard, Suite 740 South San Francisco CA CALIFORNIA 94080 Director Daniel Spiegelman c/o Spruce Biosciences, Inc. 611 Gateway Boulevard, Suite 740 South San Francisco CA CALIFORNIA 94080 Director Michael Grey c/o Spruce Biosciences, Inc. 611 Gateway Boulevard, Suite 740 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Simpson Camilla c/o Spruce Biosciences, Inc. 611 Gateway Boulevard, Suite 740 South San Francisco CA CALIFORNIA 94080 Director Tiba Aynechi c/o Spruce Biosciences, Inc. 611 Gateway Boulevard, Suite 740 South San Francisco CA CALIFORNIA 94080 Director Kirk Ways c/o Spruce Biosciences, Inc. 611 Gateway Boulevard, Suite 740 South San Francisco CA CALIFORNIA 94080 Director Samir Gharib c/o Spruce Biosciences, Inc. 611 Gateway Boulevard, Suite 740 South San Francisco CA CALIFORNIA 94080 Executive Officer Percival Barretto-Ko c/o Spruce Biosciences, Inc. 611 Gateway Boulevard, Suite 740 South San Francisco CA CALIFORNIA 94080 Director Biotechnology No Revenues 06b false 2025-10-09 false true true true Equity offering includes common stock and pre-funded warrants to purchase common stock. false 0 Leerink Partners LLC 39011 None None 53 State Street, 40th Floor Boston MA MASSACHUSETTS 02109 All States false Citizens JMP Securities, LLC 22208 None None 101 California Street, Suite 1700 San Francisco CA CALIFORNIA 94111 All States false H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue, 3rd Floor New York NY NEW YORK 10022 All States false 49999768 49999768 0 false 21 3000000 0 0 The Company shall use the net proceeds of the sale of the Securities hereunder for non-clinical and clinical development activities for its product candidate, pre-commercial activities and general corporate purposes. false SPRUCE BIOSCIENCES, INC. /s/ Samir Gharib Samir Gharib President & CFO 2025-10-16